Geron
GERN
1.19
-0.01
-0.84%
Geron
US · GERN
#3440 by market cap
1.19
-0.01
-0.84%
Live - 5344 symbols - heartbeat 467s ago
· 2026-10-08 10:00
Pre-market
1.20
0.00%
After-hours
1.20
0.00%
Overnight
1.21
+0.83%
- Market cap
- 764.48M
- P/E (TTM)i
- -10.82
- P/Bi
- 3.50
- EPSi
- -0.13
- Div yieldi
- 0.00%
- 52W posi
- 15%
Reader sentiment
Are you bullish or bearish on GERN?
Anonymous reader poll. Unscientific, not investment advice.
About Geron
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.
- Founded
- 1990
- CEO
- Mr. Harout Semerjian
- Employees
- 258
- Headquarters
- Foster City, California, United States of America
- Fiscal year end
- 12-31
- Website
- geron.com
Company profile
- Exchange
- US
- Symbol
- GERN
- Market-cap rank
- #3440
- Market cap
- 764.48M
- Float cap
- 661.95M
- Shares out
- 642.47M
- Float shares
- 556.31M
Sectors & themes
Biotechnology
Fractional Shares JP
Quote time 2026-10-08 10:00:02 · For reference only, not investment advice and not tailored to your situation.